Vivo Capital VIII, LLC Insider Trading $MNLO VYNE Therapeutics Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Vivo Capital VIII, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Vivo Capital VIII, LLC. Vivo Capital VIII, LLC is 10% Owner in IMPEL NEUROPHARMA INC ($IMPL) and 10% Owner in BioPharmX Corp ($TPND) and 10% Owner in Menlo Therapeutics, Inc. ($MNLO) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Nabriva Therapeutics plc ($NBRV) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
Vivo Capital VIII, LLC in VYNE Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Vivo Capital VIII, LLC: 10% Owner
Holdings: 258,432 shares
Latest Transaction: Jan 29 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Vivo Capital VIII, LLC in VYNE Therapeutics Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALGS, BOLT, CRNX, IMPL, NBRV, TERN, TMBR, MNLO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 341,784 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 2,475,118 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 874,817 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Option Exercise | C | 0.00 | 6,335,215 | 0 | 0 | |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 126,703 | 0 | 486,695 | 360 K to 486.7 K (+35.20 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 917,559 | 0 | 3,524,541 | 2.6 M to 3.5 M (+35.20 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 324,306 | 0 | 359,992 | 35.7 K to 360 K (+908.78 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | C | 0.00 | 2,348,550 | 0 | 2,606,982 | 258.4 K to 2.6 M (+908.77 %) |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 35,686 | 606,662 | 35,686 | 0 to 35.7 K |
| Jan 29 2018 | MNLO | Menlo Therapeutics ... | Vivo Capital VIII, LLC | 10% Owner | Buy | P | 17.00 | 258,432 | 4,393,344 | 258,432 | 0 to 258.4 K |
Page: 1